Future or investigational<unk>  of multiple<unk>  neoplasia type 2 include treatment with axitinib, gefitinib, imatinib, motesanib, sorafenib, sunitinib, vandetanib and XL184.
Multiple endocrine neoplasia type 2 future or investigational therapies
Multiple endocrine neoplasia type 1 future or investigational therapies
Multiple endocrine neoplasia type 2 secondary prevention
Multiple endocrine neoplasia type 1 secondary prevention
Multiple endocrine neoplasia type 2 medical therapy
Multiple endocrine neoplasia type 2 prevention
Multiple endocrine neoplasia type 1 medical therapy
Multiple endocrine neoplasia type 1 surgery